Cellink Life Sciences completes Nanoscribe acquisition

June 1, 2021
Nanoscribe specializes in 3D bioprinting based on two-photon polymerization technology.

On May 31, 2021, bioconvergence company Cellink Life Sciences (Gothenburg, Sweden) finalized its acquisition of Nanoscribe (Karlsruhe, Germany), a company focusing on development of high-precision 3D printers based on two-photon polymerization (2PP) technology. 

The combination of the two companies’ technologies enables Cellink to offer 2PP products for several markets, such as bioprinting, microfluidics, micro-optics, micromechanics, biomedical engineering, and integrated photonics technologies, explains Erik Gatenholm, CEO of Cellink. One example, he says, is the sample preparation steps for single-cell genomics applications.

Source: Cellink Life Sciences press release

Sponsored Recommendations

Advancing Neuroscience Using High-Precision 3D Printing

March 7, 2025
Learn how Cold Spring Harbor Laboratory Used High-Precision 3D Printing to Advance Neuroscience Research using 3D Printed Optical Drives.

From Prototyping to Production: How High-Precision 3D Printing is Reinventing Electronics Manufacturing

March 7, 2025
Learn how micro 3D printing is enabling miniaturization. As products get smaller the challenge to manufacture small parts increases.

Sputtered Thin-film Coatings

Feb. 27, 2025
Optical thin-film coatings can be deposited by a variety of methods. Learn about 2 traditional methods and a deposition process called sputtering.

What are Notch Filters?

Feb. 27, 2025
Notch filters are ideal for applications that require nearly complete rejection of a laser line while passing as much non-laser light as possible.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!